ZYBT Zhengye Biotechnology Holding Limited

Fundamentals / CIK 0001975641 / CNY

Zhengye Biotechnology Holding Limited reported ¥116.4M in revenue and a net loss of ¥69.78M for the fiscal year ended December 31, 2025 (down 37.6% year over year), with a 20.5% gross margin and a -60.6% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ZYBT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

4 fiscal years (2022 to 2025), reported in CNY.

¥263.9M¥131.9M¥0-¥87.37MFY 2022 Revenue: ¥260.3MFY 2022 Net Income: ¥46.73M2022FY 2023 Revenue: ¥211.7MFY 2023 Net Income: ¥31.46M2023FY 2024 Revenue: ¥186.4MFY 2024 Net Income: ¥11.31M2024FY 2025 Revenue: ¥116.4MFY 2025 Net Income: -¥69.78M2025

Financial statements and ratios

Reported in CNY. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in CNY · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31
Revenue ¥116.4M ¥186.4M ¥211.7M ¥260.3M
Cost of Revenue ¥92.49M ¥95.06M ¥94.14M ¥112.4M
Gross Profit ¥23.87M ¥91.30M ¥117.5M ¥147.9M
Research & Development ¥18.01M ¥12.79M ¥11.90M ¥13.42M
Selling, General & Admin ¥74.92M ¥63.84M ¥64.33M ¥58.89M
Total Operating Expenses ¥94.38M ¥74.86M ¥72.52M ¥82.05M
Operating Income -¥70.51M ¥16.44M ¥44.99M ¥65.83M
EBITDA -¥44.62M ¥40.60M ¥68.90M ¥84.63M
Interest Income ¥96K ¥231K ¥312K ¥114K
Interest Expense ¥3.40M ¥4.04M ¥4.42M ¥2.84M
Income Before Tax -¥71.87M ¥14.39M ¥43.76M ¥63.91M
Income Tax Expense ¥11.10M ¥924K ¥6.25M ¥8.17M
Net Income -¥69.78M ¥11.31M ¥31.46M ¥46.73M
Basic EPS -- ¥0.25 ¥0.69 ¥1.02
Diluted EPS -- ¥0.25 ¥0.69 ¥1.02
Basic Shares Outstanding 47.3M 45.7M 45.7M 45.7M
Diluted Shares Outstanding 47.3M 45.7M 45.7M 45.7M

Income Statement (Quarterly) · Reported in CNY · Newest filing period first.

No quarterly income statement rows are available in SEC EDGAR CompanyFacts for ZYBT.

Balance Sheet (Annual) · Reported in CNY · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents ¥50.33M ¥18.60M ¥15.07M
Short-Term Investments ¥1.56M ¥1.43M ¥1.22M
Cash & Short-Term Investments ¥51.89M ¥20.04M ¥16.30M
Accounts Receivable, Net ¥18.48M ¥59.56M ¥74.17M
Inventory ¥39.17M ¥58.22M ¥58.30M
Total Current Assets ¥137.4M ¥177.6M ¥189.2M
Property, Plant & Equipment, Net ¥236.8M ¥255.2M ¥263.2M
Intangible Assets ¥47.08M ¥14.85M ¥16.30M
Total Non-Current Assets ¥299.1M ¥315.7M ¥310.6M
Total Assets ¥436.5M ¥493.2M ¥499.9M
Accounts Payable ¥44.01M ¥42.96M ¥45.66M
Short-Term Debt ¥65.80M ¥81.63M ¥79.86M
Deferred Revenue (Current) ¥4.75M ¥3.48M ¥3.88M
Total Current Liabilities ¥120.5M ¥135.9M ¥150.2M
Long-Term Debt ¥8.85M ¥4.80M ¥9.99M
Total Non-Current Liabilities ¥9.28M ¥4.80M ¥10.38M
Total Liabilities ¥129.8M ¥140.7M ¥160.6M
Total Debt (incl. Leases) ¥75.08M ¥86.43M ¥89.85M
Common Stock -- ¥8.0K ¥8.0K
Retained Earnings -¥21.63M ¥48.15M ¥38.38M
Accumulated Other Comp. Income -¥1.93M ¥3.0K --
Total Stockholders' Equity ¥249.8M ¥284.0M ¥272.9M
Total Equity ¥306.7M ¥352.5M ¥339.3M

Balance Sheet (Quarterly) · Reported in CNY · Newest filing period first.

Balance Sheet 2025-12-31 2024-12-31 2023-12-31
Cash & Cash Equivalents ¥50.33M ¥18.60M ¥15.07M
Short-Term Investments ¥1.56M ¥1.43M ¥1.22M
Cash & Short-Term Investments ¥51.89M ¥20.04M ¥16.30M
Accounts Receivable, Net ¥18.48M ¥59.56M ¥74.17M
Inventory ¥39.17M ¥58.22M ¥58.30M
Total Current Assets ¥137.4M ¥177.6M ¥189.2M
Property, Plant & Equipment, Net ¥236.8M ¥255.2M ¥263.2M
Intangible Assets ¥47.08M ¥14.85M ¥16.30M
Total Non-Current Assets ¥299.1M ¥315.7M ¥310.6M
Total Assets ¥436.5M ¥493.2M ¥499.9M
Accounts Payable ¥44.01M ¥42.96M ¥45.66M
Short-Term Debt ¥65.80M ¥81.63M ¥79.86M
Deferred Revenue (Current) ¥4.75M ¥3.48M ¥3.88M
Total Current Liabilities ¥120.5M ¥135.9M ¥150.2M
Long-Term Debt ¥8.85M ¥4.80M ¥9.99M
Total Non-Current Liabilities ¥9.28M ¥4.80M ¥10.38M
Total Liabilities ¥129.8M ¥140.7M ¥160.6M
Total Debt (incl. Leases) ¥75.08M ¥86.43M ¥89.85M
Common Stock -- ¥8.0K ¥8.0K
Retained Earnings -¥21.63M ¥48.15M ¥38.38M
Accumulated Other Comp. Income -¥1.93M ¥3.0K --
Total Stockholders' Equity ¥249.8M ¥284.0M ¥272.9M
Total Equity ¥306.7M ¥352.5M ¥339.3M

Cash Flow Statement (Annual) · Reported in CNY · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31
Net Income -¥82.97M ¥13.47M ¥37.51M ¥55.74M
Depreciation & Amortization ¥25.88M ¥24.16M ¥23.91M ¥18.80M
Change in Receivables ¥39.71M ¥16.34M ¥31.04M -¥24.96M
Change in Inventory ¥6.25M -¥5.88M -¥12.90M -¥12.32M
Change in Payables -¥3.36M -¥404K -¥35.61M -¥9.67M
Operating Cash Flow ¥13.33M ¥41.05M ¥48.18M ¥17.34M
Capital Expenditure -¥1.01M -¥13.59M -¥7.40M -¥27.33M
Free Cash Flow ¥12.32M ¥27.46M ¥40.79M -¥9.99M
Investing Cash Flow -¥12.63M -¥27.66M -¥11.77M -¥27.33M
Dividends Paid -- -¥16.02M -¥39.45M -¥21.43M
Financing Cash Flow ¥32.31M -¥22.13M -¥18.98M ¥13.46M
Net Change in Cash ¥31.73M -¥8.58M ¥17.44M ¥3.46M

Cash Flow Statement (Quarterly) · Reported in CNY · Newest filing period first.

No quarterly cash flow statement rows are available in SEC EDGAR CompanyFacts for ZYBT.

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 20.5% 49.0% 55.5% 56.8%
Operating Margin -60.6% 8.8% 21.3% 25.3%
Net Profit Margin -60.0% 6.1% 14.9% 18.0%
Return on Equity (ROE) -27.9% 4.0% 11.5% --
Return on Assets (ROA) -16.0% 2.3% 6.3% --
Current Ratio 1.14x 1.31x 1.26x --
Quick Ratio 0.82x 0.88x 0.87x --
Debt to Equity 0.30x 0.30x 0.33x --
Revenue Growth (YoY) -37.6% -12.0% -18.7% --
Gross Profit Growth (YoY) -73.9% -22.3% -20.5% --
Operating Income Growth (YoY) -528.9% -63.5% -31.7% --
Net Income Growth (YoY) -717.0% -64.0% -32.7% --
EPS Growth (YoY) -- -63.8% -32.4% --
Operating Cash Flow Growth (YoY) -67.5% -14.8% +178.0% --
Free Cash Flow Growth (YoY) -55.1% -32.7% -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

No quarterly ratios & growth rows are available in SEC EDGAR CompanyFacts for ZYBT.
Source: SEC EDGAR CompanyFacts (CIK 0001975641) · from December 31, 2022 Data through December 31, 2025 · synced Nov 20, 2026, 05:51 UTC · Open in terminal